Unknown

Dataset Information

0

SMARCAD1 Promotes Pancreatic Cancer Cell Growth and Metastasis through Wnt/?-catenin-Mediated EMT.

ABSTRACT: Pancreatic cancer (PC) is one of the most lethal diseases, characterized by early metastasis and high mortality. Subunits of the SWI/SNF complex have been identified in many studies as the regulators of tumor progression, but the role of SMARCAD1, one member of the SWI/SNF family, in pancreatic cancer has not been elucidated. Based on analysis of GEO database and immunohistochemical detection of patient-derived pancreatic cancer tissues, we found that SMARCAD1 is more highly expressed in pancreatic cancer tissues and that its expression level negatively correlates with patients' survival time. With further investigation, it shows that SMARCAD1 promotes the proliferation, migration, invasion of pancreatic cancer cells. Mechanistically, we first demonstrate that SMARCAD1 induces EMT via activating Wnt/?-catenin signaling pathway in pancreatic cancer. Our results provide the role and potential mechanism of SMARCAD1 in pancreatic cancer, which may prove useful marker for diagnostic or therapeutic applications of PC disease.

SUBMITTER: Liu F 

PROVIDER: S-EPMC6367592 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

SMARCAD1 Promotes Pancreatic Cancer Cell Growth and Metastasis through Wnt/β-catenin-Mediated EMT.

Liu Furao F   Xia Zebin Z   Zhang Meichao M   Ding Jiping J   Feng Yang Y   Wu Jianwei J   Dong Yun Y   Gao Wei W   Han Zengwei Z   Liu Yuanhua Y   Yao Yuan Y   Li Dong D  

International journal of biological sciences 20190101 3

Pancreatic cancer (PC) is one of the most lethal diseases, characterized by early metastasis and high mortality. Subunits of the SWI/SNF complex have been identified in many studies as the regulators of tumor progression, but the role of SMARCAD1, one member of the SWI/SNF family, in pancreatic cancer has not been elucidated. Based on analysis of GEO database and immunohistochemical detection of patient-derived pancreatic cancer tissues, we found that SMARCAD1 is more highly expressed in pancrea  ...[more]

Similar Datasets

Unknown IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling.
| S-EPMC6525164 | biostudies-literature
Unknown Calpain2 Upregulation Regulates EMT-Mediated Pancreatic Cancer Metastasis <i>via</i> the Wnt/β-Catenin Signaling Pathway.
| S-EPMC9189366 | biostudies-literature
Unknown DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway.
| S-EPMC5986742 | biostudies-literature
Unknown Ginsenoside Rg3 Inhibits the Growth of Osteosarcoma and Attenuates Metastasis through the Wnt/?-Catenin and EMT Signaling Pathway.
| S-EPMC7369650 | biostudies-literature
Unknown A novel RIP1-mediated canonical WNT signaling pathway that promotes colorectal cancer metastasis via β -catenin stabilization-induced EMT.
| S-EPMC10581897 | biostudies-literature
Unknown Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/?-Catenin Signaling.
| S-EPMC4651817 | biostudies-literature
Unknown PITX2 in pancreatic stellate cells promotes EMT in pancreatic cancer cells via the Wnt/β-catenin pathway.
| S-EPMC10520469 | biostudies-literature
Unknown SOX8 promotes tumor growth and metastasis through FZD6-dependent Wnt/β-catenin signaling in colorectal carcinoma.
| S-EPMC10686890 | biostudies-literature
Unknown CAV1 promotes HCC cell progression and metastasis through Wnt/?-catenin pathway.
| S-EPMC4152279 | biostudies-literature
Unknown FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.
| S-EPMC5514503 | biostudies-literature